Announcement of Series A Funding
We have closed a third-party allotment of approximately 310 million yen to the Beyond Next Ventures No. 2 Investment Limited Partnership, Ono Venture Investment, Inc. Asahi Kasei Pharma Co., Ltd. and Gemseki Investment Limited Partnership. (Investor names are in no particular order, the same applies below) Ongoing, we will further accelerate the drug discovery business […]